Pyxis Oncology Inc.

NASDAQ: PYXS · Real-Time Price · USD
1.16
-0.04 (-3.33%)
At close: Aug 20, 2025, 3:59 PM
1.16
0.00%
Pre-market: Aug 21, 2025, 09:11 AM EDT

Pyxis Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-96.29M -95.23M -77.33M -57.36M -59.2M -57.8M -73.79M -94.29M -98.92M -108.58M -120.72M -101.44M -87.95M -70.53M -75.97M -63.73M -52.74M -47.12M
Depreciation & Amortization
2.37M 2.42M 2.98M 3.19M 2.99M 2.93M 2M 1.43M 1.11M 741K 709K 675K 634K 692K 647K 659K 769K 567K
Stock-Based Compensation
12.4M 12.26M 12.95M 13.39M 15.59M 16.38M 16.95M 17.63M 16.9M 17.24M 15.76M 14.98M 10.84M 7.39M 6.44M 3.34M 3.05M 2.48M
Other Working Capital
-9.74M -3.28M -13.1M -9.03M -11.3M -9.1M 4.05M 13.67M 15.51M 3.78M 12.83M 2.66M 925K 17.18M 2.03M 6.37M 3.84M -3.81M
Other Non-Cash Items
11.46M 10.69M 10.53M -6.1M 629K 2.27M 2.93M 9.42M 9.57M 9.71M 10.41M 1.01M 857K 619K 20.6M 20.1M 20.09M 20.19M
Deferred Income Tax
n/a n/a n/a -4.39M -5.87M -7.13M -7.13M -2.74M -1.26M n/a n/a 410K 2.97M 5.18M 6.28M 5.87M 3.31M 1.1M
Change in Working Capital
-3.7M 10.37M -6.8M -2.37M -10.68M -21.22M -11.66M -4.29M -3.21M -7.62M 4.5M 254K 1.8M 12.37M 6.68M 7.42M 3.83M -3.9M
Operating Cash Flow
-73.75M -59.5M -57.67M -53.64M -56.55M -64.58M -70.71M -72.84M -75.82M -88.5M -89.33M -84.12M -70.85M -44.27M -35.33M -26.32M -21.69M -26.68M
Capital Expenditures
n/a n/a -237K -237K -298K -2.56M -6.73M -8.58M -12.79M -10.66M -6.4M -4.94M -676K -918K -941K -540K -679K -980K
Cash Acquisitions
n/a n/a n/a 1K 6.66M -8.53M -8.53M -8.53M -15.19M n/a n/a 50K 50K 50K n/a -50K -50K -50K
Purchase of Investments
-120.46M -118.68M -160.12M -165.97M -198.76M -194.64M -196.83M -186.6M -130.18M -94.99M n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
40.75M 23.67M 31.03M 20.45M 190.7M 166.58M 92.05M 71.59M 15.19M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
137.48M 137.48M 119.22M 119.23M -18.25M -3.06M 15.11M 15.1M 15.1M -94.99K n/a -100K -100K -100K -150K -50K -50K -50K
Investing Cash Flow
57.77M 42.47M 8.15M -8.27M -1.7M -23.95M -104.85M -116.94M -127.77M -105.65M -6.4M -4.99M -726K -968K -1.04M -590K -729K -1.03M
Debt Repayment
62K 62K 62K -17K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-7.65M -7.69M -7.89M -240.05K -239.44K -196.44K -445 -393 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-60K 117K 168K 222K -37K -144K -193K -174K 3K 1K 177K 2.79M 1.07M 390K 167K -2.47M -729K -45.5K
Financial Cash Flow
1.64M 1.81M 59.33M 59.25M 57.42M 63.44M 5.93M 6.13M 6.31M 184K 360K 155.08M 153.37M 152.69M 304.04M 149.15M 150.88M 151.57M
Net Cash Flow
-14.34M -15.21M 9.81M -2.66M -824K -25.09M -169.63M -183.82M -197.46M -194.14M -95.55M 66.42M 82.25M 107.89M 268.13M 122.23M 128.47M 123.85M
Free Cash Flow
-73.75M -59.44M -57.85M -53.81M -56.79M -67.14M -77.44M -81.43M -88.61M -99.16M -95.73M -89.06M -71.52M -45.19M -36.27M -26.86M -22.37M -27.66M